U.S. RESEARCH ROUNDUP- Apollo, Blackstone, Hershey

AMC Global Media

13/08/2024 08:22

Aug 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies including Apollo, Blackstone and Hershey, on Tuesday.
    
      HIGHLIGHTS 
  

                 * Apollo  APO.N : Jefferies cuts target price to $114 from $129  
 
                 * Blackstone  BX.N : Jefferies raises target price to $147 from
 $138
 
                 * Hershey Co  HSY.N : Goldman Sachs initiates coverage with sell
 rating
 
                 * Palomar Holdings Inc  PLMR.O : KBW raises target price to $113
 from $96
 
                 * Walmart  WMT.N : CFRA raises target price by $3 to $75         
 
 
    
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in
alphabetical order.   
    
                 * Adverum Biotechnologies Inc  ADVM.O : RBC cuts target price to $12 from $15
 
                 * AIG  AIG.N : Jefferies cuts target price to $82 from $84
 
                 * Akamai Technologies Inc  AKAM.O : D.A. Davidson raises target price to $120 from $115
 
                 * Akoya Biosciences Inc  AKYA.O : Piper Sandler cuts target price to $4 from $6
 
                 * Alta Equipment Group Inc  ALTG.N : D.A. Davidson cuts target price to $12 from $20
 
                 * AMC Networks Inc  AMCX.O : TD Cowen cuts target price to $11 from $16
 
                 * Amprius Technologies Inc  AMPX.N : Northland Capital cuts target price to $4 from $10
 
                 * Apellis Pharmaceuticals Inc  APLS.O : JP Morgan cuts target price to $64 from $72
 
                 * Apollo  APO.N : Jefferies cuts target price to $114 from $129
 
                 * Ardent Health Partners Inc  ARDT.N : Stephens initiates coverage with overweight rating
 
                 * Ardent Health Partners Inc  ARDT.N : Stephens initiates coverage with price target $24
 
                 * Ares Management Corp  ARES.N : Jefferies cuts target price to $137 from $139
 
                 * Arthur J. Gallagher & Co.  AJG.N : TD Cowen raises target price to $288 from $273
 
                 * Azek Company Inc  AZEK.N : JP Morgan cuts target price to $48 from $52
 
                 * Bioventus Inc  BVS.O : Canaccord Genuity raises target price to $12 from $8
 
                 * Blackstone  BX.N : Jefferies raises target price to $147 from $138
 
                 * Boundless Bio Inc  BOLD.O : Leerink Partners cuts target price to $21 from $25
 
                 * Cambium Networks Corp  CMBM.O : Jefferies cuts target price to $1.75 from $4
 
                 * Cannae Holdings Inc  CNNE.N : Stephens cuts target price to $28 from $31
 
                 * Clearway Energy Inc  CWEN.N : RBC raises target price to $30 from $26
 
                 * CommScope Holding Company Inc  COMM.O : Jefferies raises PT to $2.50 from $1
 
                 * Compass Therapeutics Inc  CMPX.O : Leerink Partners cuts target price to $5 from $10
 
                 * Conagra Brands Inc  CAG.N : Goldman Sachs initiates coverage with buy rating
 
                 * Conagra Brands Inc  CAG.N : Goldman Sachs initiates coverage with target price $36
 
                 * Constellation Energy Corp  CEG.O : RBC cuts target price to $214 from $218
 
                 * Construction Partners Inc  ROAD.O : D.A. Davidson raises target price to $55 from $50
 
                 * Cytek Biosciences Inc  CTKB.O : Piper Sandler cuts target price to $8 from $8.5
 
                 * Danimer Scientific Inc  DNMR.N : TD Cowen cuts target price to $1 from $2
 
                 * Danimer Scientific Inc  DNMR.N : TD Cowen cuts to hold from buy
 
                 * Deere & Co  DE.N : JP Morgan cuts target price to $360 from $375
 
                 * Duke Energy Corp  DUK.N : RBC raises target price to $119 from $113
 
                 * Dyne Therapeutics Inc  DYN.O : Chardan Capital Markets raises PT to $50 from $42
 
                 * Dyne Therapeutics Inc  DYN.O : Jefferies raises target price to $50 from $42
 
                 * Dyne Therapeutics Inc  DYN.O : Piper Sandler raises target price to $53 from $43
 
                 * Envestnet Inc  ENV.N : Jefferies raises target price to $63.15 from $59
 
                 * Esperion Therapeutics Inc  ESPR.O : Needham cuts target price to $6 from $8
 
                 * Eyepoint Pharmaceuticals Inc  EYPT.O : JP Morgan cuts target price to $29 from $32
 
                 * Fortrea Holdings Inc  FTRE.O : Evercore ISI cuts target price to $22 from $27
 
                 * Fortrea Holdings Inc  FTRE.O : Jefferies cuts target price to $25 from $32
 
                 * General Mills  GIS.N : Goldman Sachs initiates coverage with buy rating
 
                 * General Mills  GIS.N : Goldman Sachs initiates coverage with target price $76
 
                 * Getty Images Holdings Inc  GETY.N : Macquarie cuts target price to $3.5 from $4
 
                 * Guardant Health Inc  GH.O : Piper Sandler raises target price to $34 from $30
 
                 * Hanover Insurance Group Inc  THG.N : KBW raises target price to $144 from $142
 
                 * Hershey Co  HSY.N : Goldman Sachs initiates coverage with sell rating
 
                 * Hershey Co  HSY.N : Goldman Sachs initiates coverage with target price $185
 
                 * Hilton Worldwide Holdings Inc  HLT.N : CFRA cuts target price to $236 from $242
 
                 * Horace Mann Educators Corp  HMN.N : KBW cuts target price to $39 from $40
 
                 * Illumina Inc  ILMN.O : Piper Sandler cuts target price to $195 from $200
 
                 * Immunome Inc  IMNM.O : Piper Sandler cuts target price to $23 from $27
 
                 * Inozyme pharma Inc  INZY.O : Jefferies assumes coverage with buy rating
 
                 * Inozyme pharma Inc  INZY.O : Jefferies assumes coverage with target price $17 vs $16
 
                 * Jeld-Wen Holding Inc  JELD.N : Jefferies cuts target price to $15 from $16
 
                 * Kellanova  K.N : Goldman Sachs initiates coverage with neutral rating; PT $75
 
                 * Keycorp  KEY.N : CFRA raises target price by $5 to $17
 
                 * Keycorp  KEY.N : CFRA raises to hold from sell
 
                 * Keycorp  KEY.N : Wedbush raises target price to $17 from $16
 
                 * Kilroy Realty Corp  KRC.N : Jefferies cuts target price to $42 from $45
 
                 * Kraft Heinz  KHC.O : Goldman Sachs initiates coverage with sell rating
 
                 * Kraft Heinz  KHC.O : Goldman Sachs initiates coverage with target price $34
 
                 * Meiragtx Holdings Plc  MGTX.O : RBC cuts target price to $9 from $11
 
                 * Mondelez  MDLZ.O : Goldman Sachs initiates coverage with buy rating
 
                 * Mondelez  MDLZ.O : Goldman Sachs initiates coverage with target price $80
 
                 * Morgan Stanley Direct Lending Fund  MSDL.N : RBC cuts target price to $22 from $23
 
                 * Myriad Genetics Inc  MYGN.O : Jefferies raises target price to $22 from $20
 
                 * Myriad Genetics Inc  MYGN.O : Piper Sandler raises target price to $30 from $28
 
                 * Natera Inc  NTRA.O : Piper Sandler raises target price to $150 from $120
 
                 * Neuronetics Inc  STIM.O : Canaccord Genuity cuts target price to $3 from $6
 
                 * Occidental Petroleum Corp  OXY.N : JP Morgan cuts target price to $71 from $73
 
                 * Occidental Petroleum Corp  OXY.N : Stephens raises target price to $77 from $76
 
                 * Pacs Group Inc  PACS.N : Oppenheimer raises target price to $40 from $32
 
                 * Palomar Holdings Inc  PLMR.O : KBW raises target price to $113 from $96
 
                 * Replimune Group Inc  REPL.O : JP Morgan cuts target price to $14 from $17
 
                 * Revance Therapeutics Inc  RVNC.O : Mizuho cuts target price to $6.66 from $8
 
                 * Revance Therapeutics Inc  RVNC.O : Needham cuts to hold from buy
 
                 * Revance Therapeutics Inc  RVNC.O : Piper Sandler cuts to neutral from overweight
 
                 * Revance Therapeutics Inc  RVNC.O : Piper Sandler raises target price to $6.66 from $6
 
                 * RXO Inc  RXO.N : Jefferies cuts target price to $31 from $33
 
                 * Savara Inc  SVRA.O : Jefferies raises target price to $8.50 from $7
 
                 * Scpharmaceuticals Inc  SCPH.O : Leerink Partners cuts target price to $20 from $22
 
                 * Syros Pharmaceuticals Inc  SYRS.O : Piper Sandler cuts target price to $5 from $13
 
                 * Talos Energy Inc  TALO.N : Stephens raises target price to $25 from $24
 
                 * Targa Resources Corp  TRGP.N : RBC raises target price to $153 from $147
 
                 * Taysha Gene Therapies Inc  TSHA.O : Needham cuts target price to $6 from $7
 
                 * Tela Bio Inc  TELA.O : Canaccord Genuity cuts target price to $12 from $14
 
                 * Tela Bio Inc  TELA.O : Jefferies cuts target price to $14 from $18
 
                 * Tela Bio Inc  TELA.O : Piper Sandler cuts target price to $8 from $10
 
                 * Transdigm Group Inc  TDG.N : Jefferies cuts target price to $1,515 from $1,625
 
                 * Travere Therapeutics Inc  TVTX.O : JP Morgan raises target price to $20 from $19
 
                 * Trubridge Inc  TBRG.O : RBC raises target price to $14 from $13
 
                 * TTEC Holdings Inc  TTEC.O : Canaccord Genuity cuts target price to $4.50 from $8
 
                 * Unitil Corp  UTL.N : RBC raises target price to $55 from $52
 
                 * US Foods Holding Corp  USFD.N : CFRA cuts target price to $55 from $63
 
                 * US Foods Holding Corp  USFD.N : CFRA cuts to hold from buy
 
                 * US Foods Holding Corp  USFD.N : JP Morgan raises target price to $60 from $58
 
                 * Vera Therapeutics Inc  VERA.O : JP Morgan cuts target price to $62 from $65
 
                 * Veracyte Inc  VCYT.O : Stephens raises target price to $34 from $32
 
                 * Vicarious Surgical  RBOT.N : TD Cowen adjusts PT to $10 from $1.50 to reflect 1-for-30 reverse stock
 split
 
                 * Victory Capital Holdings Inc  VCTR.O : RBC cuts target price to $55 from $56
 
                 * Walmart  WMT.N : CFRA raises target price by $3 to $75
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))